Loading...
Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives
Heterozygous familial hypercholesterolemia (FH) is a genetic disorder characterized by high low-density lipoprotein cholesterol levels from birth, which exposes the arteries to high levels of atherogenic lipoproteins lifelong and results in a significantly increased risk of premature cardiovascular...
Na minha lista:
| Udgivet i: | Vasc Health Risk Manag |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5590683/ https://ncbi.nlm.nih.gov/pubmed/28919772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S130338 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|